• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Trust in health sector takes a hit in major markets, Edelman research finds

Share:

May 9, 2018

Highlights on this story:
  • The high price of medicines, which is always an issue, seems to have affected some markets much more than others; France is down significantly, and Germany remains low.
  • Other findings in the broader Trust Barometer released at the start of the year point to the need for greater visibility of CEOs, in particular given a long-term downturn in trust in traditional media.

The report is a breakout from the broader Edelman Trust Barometer, which was released at the start of the year and showed a decline in public trust in major institutions in the US and globally, as well as in the UK, although the latter market did see a rise in trust in traditional media.

Overall trust in healthcare declined by two per cent to 63 per cent.

Kate Hawker, MD of health brands at Edelman UK, said: “The high price of medicines, which is always an issue, seems to have affected some markets much more than others; France is down significantly, and Germany remains low.

“The US has gone down by nine per cent – that is a market that has had quite a few pricing issues or scandals – the opioid [addiction] issue has I think mired not just pharma but trust in health more broadly; in hospitals, clinics, pharmacists.”

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Hawker pointed out that research for the report was done last year, before a number of combative statements made by President Trump about pricing and the need to tackle the opioids crisis in the US.

She also noted that there is a long-term trend for improved trust in some sub-sectors of health; hospitals and clinics score 72, up from 63 nine years ago, while health insurance firms’ score has risen from 52 to 59. Pharma is static over the period, remaining at 54.

Meanwhile, trust in healthcare in the UK fell by two per cent – a figure not seen as statistically significant at a country level – leaving the UK as one of the more trusting markets globally. None of these trusting markets saw a rise of more than two per cent. India, one of the most trusting markets, saw its score drop.

In the UK, healthcare is the second most trusted sector after education, with scores of 68 and 71 respectively. Manufacturing (65) is in third. The least trusted sectors in the UK are energy (43), financial services (46) and automotive (49).

Only two sectors, financial services and education, saw a rise in trust in the UK market, and in both cases this was by a single percentage point.

“I think healthcare still performs quite well,” says Hawker, pointing out that globally, the same pattern is repeated, with most sectors showing small declines in trust.

Other findings in the broader Trust Barometer released at the start of the year point to the need for greater visibility of CEOs, in particular given a long-term downturn in trust in traditional media.

Hawker said: “Despite the relatively small dip in trust for the health sector and neutral position for pharma, there is no room for complacency. People tell us that trust-building is the first priority for the health industry and they want CEOs to take the lead and speak out on important issues beyond business.”

Read more from Hawker on why “above-brand communications” is a key focus for her team, as well as various other UK healthcare comms leaders, in our sector analysis to mark the launch of the new PRWeek Top 150 report.

Date: May 08, 2018

Source: MM&M

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • GE HealthCare, Mayo Clinic Partner to Advance Theranostics.GE HealthCare, Mayo Clinic Partner to Advance Theranostics.
  • AstraZeneca Buys CinCor in a Deal Worth Up to $1.8BAstraZeneca Buys CinCor in a Deal Worth Up to $1.8B
  • Pharma Fever Grips Dealmakers Despite M&A Spike and a Frenzy IPO YearPharma Fever Grips Dealmakers Despite M&A Spike and a Frenzy IPO Year
  • Pyxis Oncology Successfully Completes Acquisition of ApexigenPyxis Oncology Successfully Completes Acquisition of Apexigen
  • Skylight Health to Enter into 15th State with Acquisition of Tennessee Clinic with $2.2 million in Revenue and $0.4 Million EBITDASkylight Health to Enter into 15th State with Acquisition of Tennessee Clinic with $2.2 million in Revenue and $0.4 Million EBITDA
  • Curaleaf to Acquire Nevada-Based Acres Cannabis for $70 MillionCuraleaf to Acquire Nevada-Based Acres Cannabis for $70 Million
  • Pfizer To Invest $500M In North Carolina Gene Therapy PlantPfizer To Invest $500M In North Carolina Gene Therapy Plant
  • Bankers Healthcare Group Purchases Stake in Simple Admit; Grows Patient Lending PresenceBankers Healthcare Group Purchases Stake in Simple Admit; Grows Patient Lending Presence

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications